Table 2.
long term symptomology of persons with positive SARS-CoV-2 PCR test-Zambia, July 2020
Symptomatic N=155 | Persistent symptoms N=27 | |
---|---|---|
N (%) | N (%) | |
Cough | 77 (49.7) | 10 (37.0) |
Rhinorrhea | 55 (35.5) | 5 (18.5) |
Headache | 53 (34.2) | 7 (25.9) |
Fatigue | 45 (29.0) | 4 (14.8) |
Fever | 31 (20.0) | 4 (14.8) |
Sore throat | 26 (16.8) | 2 (7.4) |
Chills | 23 (14.8) | 0 (0.0) |
Appetite | 23 (14.8) | 4 (14.8) |
Arthralgia | 20 (12.9) | 4 (14.8) |
Chest pain | 20 (12.9) | 6 (22.2) |
Myalgia | 12 (7.7) | 2 (7.4) |
Abdominal pain | 10 (6.5) | 3 (11.1) |
Diarrhea | 10 (6.5) | 0 (0.0) |
Shortness of breath | 7 (4.5) | 0 (0.0) |
Nausea | 7 (4.5) | 0 (0.0) |
Loss of taste | 5 (3.2) | 0 (0.0) |
Loss of smell | 4 (2.6) | 0 (0.0) |
Rash | 3 (1.9) | 0 (0.0) |
Conjunctivitis | 1 (0.6) | 0 (0.0) |
Wheezing | 1 (0.6) | 0 (0.0) |
Epistaxis | 1 (0.6) | 0 (0.0) |
Seizure | 0 (0.0) | 0 (0.0) |
Altered mental status | 0 (0.0) | 0 (0.0) |
Other respiratory symptoms | 0 (0.0) | 0 (0.0) |
Other neurological symptoms | 1 (0.6) | 1 (3.7) |
Other symptoms | 16 (10.3) | 1 (3.7) |